A systematic review of the efficiency of recruitment to stroke rehabilitation randomised controlled trials.

Randomised controlled trials Recruitment Rehabilitation Reporting standards Stroke Systematic review

Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
10 Jan 2020
Historique:
received: 09 08 2019
accepted: 11 12 2019
entrez: 12 1 2020
pubmed: 12 1 2020
medline: 20 11 2020
Statut: epublish

Résumé

Randomised controlled trials (RCTs) that fail to meet their recruitment target risk increasing research waste. Acute stroke RCTs experience notable recruitment issues. The efficiency of recruitment to stroke rehabilitation RCTs has not been explored. To explore recruitment efficiency and the trial features associated with efficient recruitment to stroke rehabilitation RCTs. A systematic review of stroke rehabilitation RCTs published between 2005 and 2015 identified in a search of the Cochrane Stroke Group (CSG) Trials Register from 35 electronic databases (e.g. Medline, CINAHL; EMBASE), clinical trial registers, and hand-searching. Inclusion criteria are stroke rehabilitation intervention, delivered by a member of the rehabilitation team, and clinically relevant environment. We extracted data on recruitment efficiency and trial features. We screened 12,939 titles, 1270 abstracts and 788 full texts, before extracting data from 512 included RCTs (n = 28,804 stroke survivor participants). This is the largest systematic review of recruitment to date. A third of stroke survivors screened consented to participate (median 34% (IQR 14-61), on average sites recruited 1.5 participants per site per month (IQR 0.71-3.22), and one in twenty (6% (IQR 0-13) dropped out during the RCT. Almost half (48%) of those screened in the community were recruited compared to hospital settings (27%). Similarly, almost half (47%) those screened at least 6 months after stroke participated, compared to 23% of stroke survivors screened within a month of stroke. When one recruiter screened multiple sites, a median of one stroke survivor was recruited every 2 months compared to more than two per month when there was a dedicated recruiter per site. RCT recruitment was significantly faster per site, with fewer dropouts, for trials conducted in Asia (almost three stroke survivors monthly; 2% dropout) compared to European trials (approximately one stroke survivor monthly; 7% dropout). One third of stroke survivors screened were randomised to rehabilitation RCTs at a rate of between one and two per month, per site. One in twenty did not complete the trial. Our findings will inform recruitment plans of future stroke rehabilitation RCTs. Limited reporting of recruitment details restricted the subgroup analysis performed. Prospective Register of Systematic Reviews, registration number CRD42016033067.

Identifiants

pubmed: 31924252
doi: 10.1186/s13063-019-3991-2
pii: 10.1186/s13063-019-3991-2
pmc: PMC6954526
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

68

Références

Stroke. 2006 Jan;37(1):123-8
pubmed: 16322489
BMC Med Res Methodol. 2016 Aug 11;16(1):96
pubmed: 27515557
PLoS Med. 2005 Aug;2(8):e124
pubmed: 16060722
Control Clin Trials. 1998 Apr;19(2):159-66
pubmed: 9551280
PLoS One. 2011;6(10):e25491
pubmed: 22028777
Contemp Clin Trials. 2009 Jan;30(1):40-6
pubmed: 18718555
Pain. 1998 Dec;78(3):209-16
pubmed: 9870574
Arch Dis Child. 2008 Jun;93(6):458-61
pubmed: 18495909
J Med Philos. 2004 Apr;29(2):149-78
pubmed: 15371185
BMJ. 2010 Mar 23;340:c723
pubmed: 20332510
J Int Bioethique. 2012 Jun;23(2):83-94, 177-8
pubmed: 22924194
Science. 1974 Sep 27;185(4157):1124-31
pubmed: 17835457
BMJ Open. 2013 Feb 07;3(2):null
pubmed: 23396504
J Clin Epidemiol. 2010 Aug;63(8):e1-37
pubmed: 20346624
BMJ Open. 2014 Feb 04;4(2):e003821
pubmed: 24496696
Lancet. 2011 May 14;377(9778):1693-702
pubmed: 21571152
Adv Health Sci Educ Theory Pract. 2013 Mar;18(1):15-31
pubmed: 22314942
Nat Rev Neurosci. 2013 May;14(5):365-76
pubmed: 23571845
PLoS One. 2013;8(3):e59202
pubmed: 23544056
Int J Surg. 2007 Feb;5(1):57-65
pubmed: 17386916
J Pers Soc Psychol. 1968 Apr;8(4):377-83
pubmed: 5645600
Fam Pract. 2003 Feb;20(1):83-92
pubmed: 12509377
Lancet. 2002 Mar 2;359(9308):781-5
pubmed: 11888606
Trials. 2009 Jul 10;10:52
pubmed: 19591685
J Neurosci Nurs. 2012 Apr;44(2):105-10
pubmed: 22367274
Lancet. 2009 Jul 4;374(9683):86-9
pubmed: 19525005
Trials. 2015 Oct 20;16:473
pubmed: 26482231
BMC Med Res Methodol. 2001;1:4
pubmed: 11423002
BMJ. 2009 Apr 06;338:a3166
pubmed: 19349342
J Pers Soc Psychol. 2002 Oct;83(4):843-53
pubmed: 12374439
Psychol Bull. 2002 Jan;128(1):3-72
pubmed: 11843547
Psychol Bull. 2011 Jul;137(4):517-37
pubmed: 21534650
Neurology. 2016 Apr 19;86(16):1543-51
pubmed: 27009262
Lancet. 2014 Jan 11;383(9912):176-85
pubmed: 24411646
Cochrane Database Syst Rev. 2013 Dec 03;(12):MR000032
pubmed: 24297482
Lancet. 1996 Feb 10;347(8998):363-6
pubmed: 8598702
Stroke. 2013 Dec;44(12):3298-304
pubmed: 24114452
Lancet. 2014 Jan 18;383(9913):245-54
pubmed: 24449944
Trials. 2018 Mar 1;19(1):147
pubmed: 29490702
Trials. 2006 Apr 07;7:9
pubmed: 16603070
Cochrane Database Syst Rev. 2010 Jan 20;(1):MR000013
pubmed: 20091668
Trials. 2013 Jun 09;14:166
pubmed: 23758961
Stroke. 2017 Mar;48(3):799-801
pubmed: 28104835
BMJ. 1999 Sep 11;319(7211):670-4
pubmed: 10480822
J Clin Epidemiol. 2000 May;53(5):485-9
pubmed: 10812320
Am J Public Health. 2014 Feb;104(2):e16-31
pubmed: 24328648

Auteurs

Kris McGill (K)

Nursing Midwifery and Allied Health Professionals Research Unit, Glasgow Caledonian University, Glasgow, UK. Kris.mcgill@gcu.ac.uk.

Catherine M Sackley (CM)

King's College London, London, UK.

Jon Godwin (J)

Glasgow Caledonian University, Glasgow, UK.

Jodie McGarry (J)

Glasgow Caledonian University, Glasgow, UK.

Marian C Brady (MC)

Nursing Midwifery and Allied Health Professionals Research Unit, Glasgow Caledonian University, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH